A detailed history of Manufacturers Life Insurance Company, The transactions in Xencor Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 109,716 shares of XNCR stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,716
Previous 119,988 8.56%
Holding current value
$2.27 Million
Previous $2.27 Million 2.86%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.7 - $21.65 $161,270 - $222,388
-10,272 Reduced 8.56%
109,716 $2.21 Million
Q2 2024

Aug 14, 2024

BUY
$18.21 - $24.5 $402,568 - $541,621
22,107 Added 22.59%
119,988 $2.27 Million
Q1 2024

May 14, 2024

BUY
$18.65 - $26.52 $266,508 - $378,970
14,290 Added 17.1%
97,881 $2.17 Million
Q4 2023

Feb 13, 2024

SELL
$16.53 - $21.42 $9,141 - $11,845
-553 Reduced 0.66%
83,591 $1.77 Million
Q3 2023

Nov 15, 2023

BUY
$20.08 - $25.39 $82,990 - $104,936
4,133 Added 5.17%
84,144 $1.7 Million
Q2 2023

Aug 11, 2023

BUY
$24.77 - $29.9 $175,000 - $211,243
7,065 Added 9.69%
80,011 $2 Million
Q1 2023

May 15, 2023

BUY
$25.95 - $36.95 $360,134 - $512,792
13,878 Added 19.03%
86,824 $2.42 Million
Q4 2022

Aug 11, 2023

BUY
$24.79 - $30.86 $2,231 - $2,777
90 Added 0.12%
72,946 $1.9 Million
Q4 2022

Feb 13, 2023

BUY
$24.79 - $30.86 $2,231 - $2,777
90 Added 0.12%
72,946 $1.9 Million
Q3 2022

Aug 11, 2023

SELL
$24.62 - $32.44 $12,137 - $15,992
-493 Reduced 0.67%
72,856 $1.89 Million
Q3 2022

Nov 03, 2022

SELL
$24.62 - $32.44 $12,137 - $15,992
-493 Reduced 0.67%
72,856 $1.87 Million
Q2 2022

Aug 11, 2023

SELL
$19.74 - $29.01 $5,152 - $7,571
-261 Reduced 0.35%
73,349 $2.01 Million
Q2 2022

Aug 15, 2022

SELL
$19.74 - $29.01 $5,152 - $7,571
-261 Reduced 0.35%
73,349 $2 Million
Q1 2022

Aug 11, 2023

SELL
$26.68 - $41.63 $352,549 - $550,098
-13,214 Reduced 15.22%
73,610 $1.96 Million
Q1 2022

May 20, 2022

BUY
$26.68 - $41.63 $1.19 Million - $1.86 Million
44,693 Added 154.56%
73,610 $2 Million
Q4 2021

Feb 16, 2022

SELL
$33.67 - $43.44 $11,043 - $14,248
-328 Reduced 1.12%
28,917 $1.17 Million
Q3 2021

Nov 12, 2021

SELL
$30.65 - $35.68 $91,153 - $106,112
-2,974 Reduced 9.23%
29,245 $955,000
Q2 2021

Aug 12, 2021

BUY
$34.33 - $44.68 $24,820 - $32,303
723 Added 2.3%
32,219 $1.11 Million
Q1 2021

May 03, 2021

SELL
$40.81 - $53.88 $77,130 - $101,833
-1,890 Reduced 5.66%
31,496 $1.36 Million
Q4 2020

Feb 12, 2021

BUY
$36.63 - $47.63 $44,102 - $57,346
1,204 Added 3.74%
33,386 $1.46 Million
Q3 2020

Nov 09, 2020

SELL
$30.09 - $43.02 $27,652 - $39,535
-919 Reduced 2.78%
32,182 $1.25 Million
Q2 2020

Aug 10, 2020

BUY
$27.76 - $33.42 $75,257 - $90,601
2,711 Added 8.92%
33,101 $1.07 Million
Q1 2020

May 15, 2020

BUY
$20.69 - $37.79 $36,000 - $65,754
1,740 Added 6.07%
30,390 $908,000
Q4 2019

Feb 14, 2020

SELL
$32.75 - $41.43 $30,359 - $38,405
-927 Reduced 3.13%
28,650 $985,000
Q3 2019

Nov 12, 2019

SELL
$33.73 - $46.27 $3,642 - $4,997
-108 Reduced 0.36%
29,577 $1.01 Million
Q2 2019

Aug 14, 2019

SELL
$29.6 - $40.93 $28,475 - $39,374
-962 Reduced 3.14%
29,685 $1.22 Million
Q1 2019

May 13, 2019

BUY
$27.85 - $38.09 $51,968 - $71,075
1,866 Added 6.48%
30,647 $952,000
Q4 2018

Feb 14, 2019

SELL
$32.39 - $42.05 $48,552 - $63,032
-1,499 Reduced 4.95%
28,781 $1.04 Million
Q3 2018

Nov 14, 2018

SELL
$35.69 - $47.65 $152,110 - $203,084
-4,262 Reduced 12.34%
30,280 $1.18 Million
Q2 2018

Aug 14, 2018

BUY
$28.41 - $42.41 $159,834 - $238,598
5,626 Added 19.46%
34,542 $1.28 Million
Q1 2018

May 15, 2018

SELL
$21.18 - $33.78 $17,452 - $27,834
-824 Reduced 2.77%
28,916 $867,000
Q4 2017

Feb 08, 2018

BUY
$19.29 - $24.83 $2,835 - $3,650
147 Added 0.5%
29,740 $652,000
Q3 2017

Nov 14, 2017

BUY
$19.61 - $23.35 $580,318 - $690,996
29,593
29,593 $678,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.